Riskpilot← Back to searchSign inGet full accessForward Pharma Operations ApS
APSIn liquidationCVR 38757504Strandvejen 125Research and experimental development on natural sciences and engineering · NACE 7210Est. 2017— employees
Revenue 2024
DKK 99K
-82% vs 2023
EBITDA margin
-2273.4%
+4% vs 2023
Equity ratio
80.1%
Financial strength
Net profit 2024
DKK -68,3M
-6651% vs 2023
| Revenue | DKK 99K | -82% |
| EBITDA | DKK -2,3M | +4% |
| Net profit | DKK -68,3M | -6651% |
| Total assets | DKK 349,4M | +16% |
| Equity | DKK 280M | +0% |
| Employees | — | — |
Legal name
Forward Pharma Operations ApS
CVR number
38757504
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30. juni 2017
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Strandvejen 125
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.653 | 105 | 327 | 351 | 622 | 724 | 547 | 99 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -29.135 | -27.060 | -11.251 | -8.158 | -9.004 | -7.895 | -2.342 | -2.254 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -29.135 | -27.060 | -11.251 | -8.158 | -9.004 | -7.895 | -2.342 | -2.254 |
| Net financials | -2.803 | 11.251 | 3.704 | -1.951 | -483 | -19.127 | 3.385 | -66.067 |
| Profit before tax | -31.938 | -15.808 | -7.547 | -10.109 | -9.487 | -27.022 | 1.043 | -68.320 |
| Tax | -6.893 | -17 | -0 | -0 | -0 | -0 | -0 | 23 |
| Net profit | -25.045 | -15.791 | -7.547 | -10.109 | -9.487 | -27.022 | 1.043 | -68.344 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 645.981 | 364.403 | 346.717 | 337.159 | 327.107 | 305.109 | 302.114 | 349.447 |
| Equity | 640.311 | 332.248 | 324.701 | 314.592 | 305.105 | 278.083 | 279.126 | 280.041 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5.653 | 32.155 | 22.016 | 22.567 | 22.001 | 27.026 | 22.988 | 69.406 |
| Total debt | 5.653 | 32.155 | 22.016 | 22.567 | 22.001 | 27.026 | 22.988 | 69.406 |
EBITDA margin
-2273.4%
This company
15.8%
Market median
-14489% vs market
20172024
Equity ratio
80.1%
This company
38.2%
Market median
+110% vs market
20172024
Return on equity
-24.4%
This company
18.4%
Market median
-233% vs market
20172024
Net profit margin
-68945.7%
This company
8.1%
Market median
-851281% vs market
20172024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-06-30 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CB Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
JM Unofficial title | Unofficial title | 2025 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
FORWARD PHARMA A/S | Company | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Forward Pharma Operations ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claus Bo Søndergaard Svendsen | Chief Executive Officer | 0 companies |
| Jakob Mosegaard Larsen | Unofficial title | 0 companies |